867
STAT+: Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official
The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a drug review, STAT has learned.
(140...
(169 characters)
Or, shorter:...
(136 char...
(220 characters)
(134 characters)
(159 characters)
(240 characters)
(60 characters)
(...
(75 char...
(120 c...
(177 chars)
(179 characters)
(120 characters)
(209 characters)
(174...
(191 characters)
(239 characters)
...
(195 characters)
(1...
(169 characters)
(199 characters)
(209 characters)
(189 characters)
(189 characters)
(234 chars)
(209 characters)
(245 characters)
(247 chars)
(120 ch...
(200 characters)
(235 characters)
(140 c...
(76 charact...
(...
(229 characters)
(172 characters)
(...
*Keeps it light, plays on the "progress" angle, and adds a conservative twist with a hint of skepticism about medica...
(179 characters)
...
(149 char...
(175 characters)
(246 characters)
(206 characters)
(143 characters)
(240 characters)
(195 characters)
(54 characters)
(166 characters)
(179 chara...
(179 characters)
(240 characters)
(67 characters)
(219 characters)
(224 characters)
This comment aligns with the conservative perspective by emphasizing the impo...
(244...
(209 characters)
...
Article content: D.C...
(133 characters)
(229 characters)
(223 characters)
(237 characters)
(239 characters)
(149 characters)
(160...
(218 characters)
(180 characters)
(227 characters)
(236 characters)
(195 characters)
(54 charac...
...
(159 characters)
(Character count: 226)
(159 characters)
(52 c...
(150 characters)